Literature DB >> 28459612

Patient Financial Assistance Programs: A Path to Affordability or a Barrier to Accessible Cancer Care?

S Yousuf Zafar1, Jeffrey M Peppercorn1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28459612      PMCID： PMC6553813          DOI： 10.1200/JCO.2016.71.7280

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

Review 1.  Future cancer research priorities in the USA: a Lancet Oncology Commission.

Authors:  Elizabeth M Jaffee; Chi Van Dang; David B Agus; Brian M Alexander; Kenneth C Anderson; Alan Ashworth; Anna D Barker; Roshan Bastani; Sangeeta Bhatia; Jeffrey A Bluestone; Otis Brawley; Atul J Butte; Daniel G Coit; Nancy E Davidson; Mark Davis; Ronald A DePinho; Robert B Diasio; Giulio Draetta; A Lindsay Frazier; Andrew Futreal; Sam S Gambhir; Patricia A Ganz; Levi Garraway; Stanton Gerson; Sumit Gupta; James Heath; Ruth I Hoffman; Cliff Hudis; Chanita Hughes-Halbert; Ramy Ibrahim; Hossein Jadvar; Brian Kavanagh; Rick Kittles; Quynh-Thu Le; Scott M Lippman; David Mankoff; Elaine R Mardis; Deborah K Mayer; Kelly McMasters; Neal J Meropol; Beverly Mitchell; Peter Naredi; Dean Ornish; Timothy M Pawlik; Jeffrey Peppercorn; Martin G Pomper; Derek Raghavan; Christine Ritchie; Sally W Schwarz; Richard Sullivan; Richard Wahl; Jedd D Wolchok; Sandra L Wong; Alfred Yung
Journal:  Lancet Oncol       Date:  2017-10-31       Impact factor: 41.316

2.  Use of Charity Financial Assistance for Novel Oral Anticancer Agents.

Authors:  Adam J Olszewski; Andrew R Zullo; Christopher R Nering; Justin P Huynh
Journal:  J Oncol Pract       Date:  2018-02-13       Impact factor: 3.840

3.  Identifying a cut-off score for the COST measure to indicate high financial toxicity and low quality of life among cancer patients.

Authors:  Marques S N Ng; Kai Chow Choi; Dorothy N S Chan; Cho Lee Wong; Weijie Xing; Pui Shan Ho; Cecilia Au; Mandy Chan; Man Tong; Wai Man Ling; Maggie Chan; Suzanne S S Mak; Raymond J Chan; Winnie K W So
Journal:  Support Care Cancer       Date:  2021-04-02       Impact factor: 3.603

4.  Financial toxicity - An overlooked side effect.

Authors:  Margaret I Liang; Warner K Huh
Journal:  Gynecol Oncol       Date:  2018-05-31       Impact factor: 5.482

5.  The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?

Authors:  Whitney N Goldsberry; Sarah S Summerlin; Allison Guyton; Brittani Caddell; Warner K Huh; Kenneth H Kim; Margaret I Liang
Journal:  Gynecol Oncol       Date:  2021-01-04       Impact factor: 5.482

6.  Total and out-of-pocket costs for PARP inhibitors among insured ovarian cancer patients.

Authors:  Margaret I Liang; Ling Chen; Dawn L Hershman; Grace C Hillyer; Warner K Huh; Allison Guyton; Jason D Wright
Journal:  Gynecol Oncol       Date:  2020-12-27       Impact factor: 5.482

7.  Financial assistance programs for cancer patients.

Authors:  Steven S Coughlin; Lorraine T Dean; Jorge E Cortes
Journal:  Curr Cancer Rep       Date:  2021-09-17

Review 8.  Evidence of the Feasibility and Preliminary Efficacy of Oncology Financial Navigation: A Scoping Review.

Authors:  Meredith J Doherty; Bridgette Thom; Francesca Gany
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-02       Impact factor: 4.090

9.  Mobile Application to Identify Cancer Treatment-Related Financial Assistance: Results of a Randomized Controlled Trial.

Authors:  Aaron M Tarnasky; George N Tran; Jonathan Nicolla; Fred A P Friedman; Steven Wolf; Jesse D Troy; Anthony D Sung; Kanan Shah; Jakob Oury; Jillian C Thompson; Ben Gagosian; Kathryn I Pollak; Ian Manners; S Yousuf Zafar
Journal:  JCO Oncol Pract       Date:  2021-04-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.